Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00666731 · ClinicalTrials.gov registry record
Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 4,945
- Enrollment target
NCT00666731: Completed study, sponsored by University of Nebraska.
NCT00666731 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 4,945 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00666731 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 4,945 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about patients with breast cancer and their families may help the study of breast cancer in the future. PURPOSE: This clinical trial is gathering information about patients with breast cancer and their families.
Primary Outcome
Web-based registry
Interventions
- OTHER medical chart review
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- OTHER study of socioeconomic and demographic variables
- PROCEDURE Excess human biological tissue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,945 participants |
| Start Date | 2006-10-12 |
| Est. Completion | 2016-08-19 |
What the finished NCT00666731 record still lists
NCT00666731 is an observational study that tracks outcomes without assigning an intervention. Its 4,945 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 5 interventions - of which medical chart review is the first listed.
NCT00666731 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00666731 about?
NCT00666731 is a clinical study titled "Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer". RATIONALE: Gathering information about patients with breast cancer and their families may help the study of breast cancer in the future. PURPOSE: This clinical trial is gathering information about patients with breast cancer and their families.
What is the current status of trial NCT00666731?
This trial is currently completed. The enrollment target is 4,945 participants. The study started on 2006-10-12. Estimated completion is 2016-08-19.
What interventions are being tested in trial NCT00666731?
The interventions under investigation include: medical chart review (OTHER), questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), study of socioeconomic and demographic variables (OTHER), Excess human biological tissue (PROCEDURE).
Who is sponsoring clinical trial NCT00666731?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05929976 · 4,900 participants
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI